Antithymocyte globulin (ATG), a horse antihuman thymus antiserum highly effective in the majority of patients with aplastic anemia, was studied for its in vitro effects on hematopoietic progenitor cells. Marrow cells isolated by an immunoadherence technique with the HPCA-1 (human progenitor cell antigen) monoclonal, antibody after removal of contaminating T cells and macrophages formed erythroid colonies in methyl cellulose media in the presence of ATG at concentrations of 25-50 ,ug/ml. ATG also stimulated continuous production of hemoglobin-containing erythroid colonies beyond 35 days of culture when it was added to the culture weekly. ATG also had an indirect effect on myeloid (granulocytic and macrophagic) colony growth in vitro. At a concentration of 10 jtg/ml, ATG stimulated late but not early myeloid progenitor cells to form mature colonies. This effect required the participation of lymphocytes containing the Leu-11 antigen and macrophages or supernatant fluids made from these two types of cells that had been preincubated with ATG for 3 hr and then cultured for 5 additional days. The supernatant fluids produced in such a manner showed characteristics similar to granulocyte colony-stimulating factor and had an activity peak that elUted at a volume corresponding to a 20,000 Da molecular mass protein by high-resolution liquid chromatography.
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Antithymocyte globulin (ATG), the IgG fraction of a xenogeneic antiserum produced by immunization of horses with human thymus tissue, has become an accepted therapeutic agent for the majority of patients with aplastic anemia. The ATG currently available is not specific for thymocytes. It also reacts with a variety of human tissue cells, including all circulating lymphocytes, granulocytes, marrow cells, erythrocytes, platelets, and cells of other human organs (1) . Fifty to 70% of patients with aplastic anemia treated with ATG recover their hematologic values either completely or to a functional degree without dependence on transfusion (2) . The hematopoietic recovery seen in the treated patients is thought by some investigators, who consider most cases of aplastic anemia to be immunologically related, to be due to ATG's immunosuppressive properties (2) (3) (4) . Other investigators have postulated that the hematologic recovery might be related to hematopoietic stimulation by ATG (5-7).
Gascon et al. (5) reported that supernatant fluids from lymphocytes cultured in the presence of ATG could replace lectin-conditioned medium in supporting colony growth of marrow progenitor cells. It is unclear whether the marrow growth stimulation observed by them was due to the growth factors in the supernatant fluids or the residual ATG, In our attempt at exploring the effects of ATG on bone marrow hematopoietic cells, we discovered that ATG stimulates the production of tight spherical myeloid colonies containing mature elements after 4 days of incubation without added colony-stimulating factor (CSF). These colonies contain granulocytes of progressively maturing morphology, indicating both proliferation and differentiation (6) .
A recent report by Mangan et al. indicated that the addition of ATG to marrow culture stimulated erythroid colony growth but only in the presence of accessory cells (7) . In our present report, we provide evidence for two separate effects of ATG on marrow growth and differentiation. We find that ATG in the presence of erythropoietin (EPO) stimulates the growth of erythroid colonies from HPCA-1 (human progenitor cell antigen) positive cells obtained by an immunoadherence procedure (panning). We also report that ATG stimulates cells expressing the Leu-11 antigen Determination of Molecular Mass. The supernatant fluid was concentrated 10-fold using an Amicon B15 filter and then was applied on an HPLC gel filtration column (9.4 x 25 cm) previously equilibrated with 0.1 M phosphate buffer, pH 7.0.
The column was standardized with albumin (66,000 Da), carbonic anhydrase (29,000 Da), aprotinin (6500 Da), and cytochrome C (12,400 Da) and was run at a flow rate of 1 ml/min.
RESULTS
Effect of ATG on Peripheral Blood Erythroid Progenitor Cells. T3' and Leu-11' cells were removed from nonadherent mononuclear cells of peripheral blood by panning. HPCA-1 cells were obtained from the T3-Leu-11-fraction by panning. The human progenitor cell antigen, HPCA-1, normally present on approximately 1% of bone marrow cells and found specifically on CFU-GM, BFU-E, CFU-E, and CFU-GEMM progenitor cells is not found on normal peripheral blood T or B lymphocytes, monocytes, granulocytes, or platelets. In our experiments, HPCA-1 cells from peripheral blood were cultured without the addition of burst-promoting factor (BPF). EPO was added on day 3 in order to reduce the number of background colonies. A definite stimulatory effect was seen with the addition of ATG in experiments using peripheral blood from four separate donors ( , and centrifuged for 6 min at 200 x g. A drop of FCS was added to the cell pellet, and cytospin slides were made. Erythroid colonies were identified using Wright's stain. Some of the larger colonies contained more than 500 cells (Fig. 1) . Although the majority of colonies were erythroid in nature, 10-20% of them were mixed colonies containing granulocytes and MO in addition to erythroid elements. Only colonies containing >60% erythroid cells were counted as erythroid colonies. As can be seen in Table 2 , ATG stimulated erythroid colony growth. Early erythroid cells dominated in cultures from 4 to 10 days. By day 13, the majority of erythroid cells had acquired hemoglobin and had begun karyorrhexis, and some had expelled the nuclei.
Long (6) (Fig. 2) . We also showed that removal of T lymphocytes using two different pan-T monoclonal antibodies (T3 and 3A1) reduced but did not abolish the growth of these colonies. Inasmuch as the monoclonal antibody 3A1 may remove some Leu-11+ lymphocytes, we considered it necessary to determine whether the reduction in growth could be due to the lack of Leu-11+ cells in the culture. In the present study, we found that removal of Leu-11+ lymphocytes and M4 markedly reduced the growth of these colonies by more than 95%. As seen in Table 3 Table   4 shows the growth of spherical myeloid colonies with various concentrations of supernatant made from Leu-11' lymphocytes and MO preincubated with ATG. Peak activity was seen at a concentration of 10-20%. Supernatant fluids produced from Leu-11 + cells alone or from T3 + lymphocytes, MO, or both combined preincubated with ATG had a much poorer stimulatory activity. The most active supernatant fluids were produced by incubation for 5-7 days. No activity was seen after only 1 day of incubation.
Supernatant fluids from Leu-11' lymphocytes and MO preincubated with ATG were concentrated and chromatographed on a high-resolution HPLC gel filtration column. The activity eluted at a volume correspondent to a molecular mass of 20,000 Da.
DISCUSSION
In our search for mechanisms leading to the recovery of the erythroid compartment in aplastic anemia patients, we decided to look at the effect of ATG on erythroid progenitor cells in peripheral blood where BFU-E are relatively more prevalent, compared with other progenitors, than in bone marrow. We used an HPCA-1' population from peripheral blood, which is enriched for early progenitor cells. No BPF was added. In the absence of BPF, colonies were somewhat smaller and showed less hemoglobin accumulation. ATG did not take the place of BPF because colonies remained small with little hemoglobin, but it did cause an increase in the number of colonies. ATG is either having a direct stimulatory effect on the BFU-E progenitor cell or is producing a BFU-E growth factor by stimulating another cell present in the HPCA-1+ population. It will be necessary to make a supernatant fluid from HPCA-1+ cells to test the latter possibility.
We then looked at the effect of ATG on bone marrow erythroid progenitor cells, which are less affected by the absence of BPF. We were able to transfer whole cultures to slides by diluting the methyl cellulose in Hanks' balanced salt solution and spinning the cell pellet in a cytocentrifuge. Using Wright's stain, we were able to identify erythroid colonies in the presence of ATG. These colonies were also present in control cultures containing preimmune horse IgG but were fewer in number. Colonies from the same day of culture were often asynchronous. Different When we looked at the effect of ATG on long-term cultures, once again we found stimulation of erythroid colony growth. Colonies continue to appear and grow beyond 35 days in the presence of ATG but not preimmune horse IgG. We know that ATG binds to HPCA-1 cells (data not shown), but we have not looked at the binding of ATG to the fibroblasts now present in the long-term cultures. Testing the supernatant fluid from these cultures will determine if it contains an erythroid growth factor(s). An in-depth study of long-term cultures may reveal the mechanism by which ATG stimulates erythroid growth and promotes the hematologic recovery of aplastic anemia patients.
We have previously reported that ATG induces the growth and differentiation of myeloid colonies in bone marrow cultures in 3-4 days. Now we have shown that these tight spherical colonies are dependent upon the presence of Leu-11+ cells and Mo. It appears that very few Mo are needed, and a surplus of M4 may be inhibitory. This cell requirement could be replaced by a supernatant made from Leu-11+ cells and Mo incubated for 3 hr with ATG followed by thorough washing and then incubation in fresh media for 5 days. The activity of a growth and differentiation factor present in this supernatant closely resembles that of CSFgranulocytes/macrophages (G-CSF). It has a molecular mass of about 20,000 Da. It acts on only a subpopulation of bone marrow progenitor cells (we were unable to grow tight spherical differentiated colonies from HPCA-1+ cells, which include CFU-GM). This factor shows enhanced differentiation not seen with CSF-granulocytes/macrophages (GM-CSF), and T cells are not able to produce the factor. If ATG is able to induce the production of G-CSF in vivo by stimulating Leu-11+ cells, then the number of these cells may be an important parameter for hematologic recovery of the patient.
